J&J Prostate Cancer Drug Shows Positive Results in Late-Stage Study

A late-stage study has revealed that Johnson & Johnson's prostate cancer drug significantly reduces the risk of cancer spread and death. This finding marks a potential advancement in prostate cancer treatment.